Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia

Not Applicable

Completed

• Conditions: Trigeminal Neuralgia
• Interventions: Other: Low level laser therapy (LLLT); Other: Electromagnetic therapy.

• Registration Number: NCT05075707
• Lead Sponsor: Delta University for Science and Technology

Brief Summary

Trigeminal neuralgia (TN) was defined by The International Association for the Study of Pain (IASP) as severe, sudden, usually unilateral, stabbing, brief, recurrent attacks of pain in one or more distributional branches of the trigeminal nerve. The purpose of the current study will to investigate the effect of Low level laser therapy versus electromagnetic therapy on diabetic trigeminal neuralgia pain intensity and amplitude of the compound muscle action potential of the masseter and temporalis muscles in diabetic TN patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-09-19
• Study First Submitted QC: 2021-09-29
• Study First Posted: 2021-10-13
• Study Start: 2021-10-15
• Primary Completion: 2022-02-22
• Study Completion: 2022-02-23
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-11
• Last Update Posted: 2022-03-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• All participants will between the ages of 25 and 45, will of both sexes (male and female), diabetic type two patients with chronic trigeminal neuralgia, (from three to six months).
• Patients will awake, cooperative, and free of psychiatric issues (as determined by a psychologist) as well as difficulties resulting from orthopaedic or special sensory deficits.

Read More

Exclusion Criteria

• Patients will ruled out if they developed TN due to a tumour, herpes zoster, or any other reason other than diabetes, such as significant coagulation dysfunction, cardiopulmonary dysfunction or previous invasive treatment (ethanol, radiofrequency, Gama-knife microvascular decompression, glycerinum injection).
• They will not have a previous disability in the face.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
low laser therapy group	Low level laser therapy (LLLT)	Participants will receive the descriptive medication by neurologist in addition to low laser therapy. Low laser therapy will be applied for 20 min/session for three days each week for two months.
electromagnetic group	Electromagnetic therapy.	Participants will receive the descriptive medication by neurologist in addition to electromagnetic therapy. Electromagnetic therapy will be applied for 20 min/session for three days each week for two months.

Primary Outcome Measures

Name	Time	Method
Studies using electromyography and complex muscle action potentials	by the end of successful two month of intervention	All patients' compound motor action potential amplitudes in the masseter and temporalis muscles will be evaluated after two month of interventions.
Visual analogue scale (VAS)	by the end of successful two month of intervention	All the participants were instructed to express their pain by Visual analogue scale (VAS) after two month of interventions.

Trial Locations

Locations (1)

AAA; 🇪🇬 Cairo, Egypt